Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87
FreeObituary

Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87

Arnold Daniel “Arnie” Kaluzny, PhD, longtime adviser to NCI and an early pioneer and contributor to what is now known as health services research, died Oct. 29 at the age of 87. 
November 21, 2025
Vol.51 No.43
By Donna M. O’Brien and Barnett Kramer
In Brief

Mount Sinai Tisch Cancer Center receives Comprehensive designation and funding from NCI

The Mount Sinai Tisch Cancer Center received the Comprehensive Cancer Center designation from NCI. 
November 21, 2025
Vol.51 No.43
Site visits are gone, but outlook for new, centralized CCSG review is bright
Podcast

Site visits are gone, but outlook for new, centralized CCSG review is bright

One of the first things that happened as part of President Donald Trump’s “flooding of the zone” in January was the disappearance of the site visit as part of the Cancer Center Support Grant review.
November 05, 2025
Cancer centers adapt to life without site visits as NIH changes CCSG review
NCINews Analysis

Cancer centers adapt to life without site visits as NIH changes CCSG review

Love them or hate them, site visits have been a part of the culture of NCI-designated cancer centers for decades, shaping the process for admitting members to the elite club and influencing internal politics within institutions.
October 31, 2025
Vol.51 No.40
By Paul Goldberg
Vinai Gondi, Bridget Koontz, Priya Rastogi, Lisa Lenrow named to NRG Oncology committee leadership
In Brief

Vinai Gondi, Bridget Koontz, Priya Rastogi, Lisa Lenrow named to NRG Oncology committee leadership

Vinai GondiBridget KoontzPriya RastogiLisa LenrowNRG Oncology, an NCI National Clinical Trials Network group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple committees.
October 31, 2025
Vol.51 No.40
Cancer Policy

Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting

NCI officials were notably absent from the annual meeting of the Association of American Cancer Institutes and the Cancer Center Administrators Forum in Washington, DC, due to the government shutdown that started on Oct. 1. 
October 24, 2025
Vol.51 No.39
By Sara Willa Ernst
Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
Guest Editorial

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

When the idea of looking at cancer center funding and the cancer burden of cancer center catchment areas came to us in the summer of 2024, we lived in a different context. 
October 17, 2025
Vol.51 No.38
By Todd Burus, Caree McAfee and Pamela C. Hull
Anthony Letai sworn in as 18th NCI director
NCI

Anthony Letai sworn in as 18th NCI director

Anthony G. Letai, accompanied by his wife Jean, was sworn in by HHS Secretary Kennedy as the 18th NCI Director on Sept. 29.Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute, has been officially named the 18th director of the National Cancer Institute.
October 03, 2025
Vol.51 No.36
By Claire Marie Porter
U.S. government shuts down
Capitol Hill

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026.
October 03, 2025
Vol.51 No.36
By Claire Marie Porter
Trump signs order to use AI to accelerate pediatric cancer research
Cancer Policy

Trump signs order to use AI to accelerate pediatric cancer research

President Trump has signed an executive order to use artificial intelligence to accelerate research in pediatric cancers.
October 03, 2025
Vol.51 No.36
By Claire Marie Porter

Posts navigation

12…36Next

Trending Stories

  • Christine Lovly to lead City of Hope’s new national thoracic oncology program
  • Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
  • FDA to remove black box warnings on hormone therapy for menopause
    Trump-era “gold standard science” is not to be confused with gold standard of scientific evidence
  • Rick Pazdur’s CDER appointment comes at exactly the right moment for FDA
  • Smoldering multiple myeloma: Rethinking the waiting game
  • Richard Pazdur, a respected insider with a plan to reengineer FDA, steps in as CDER director

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account